# Saving Little Lives Minimum Care Package Interventions in 290 Public Health Facilities in Ethiopia: Protocol for a Non-Randomized Stepped-Wedge Cluster Implementation Trial

**Authors:** Abiy Seifu Estifanos, Abebe Gebremaraim Gobezayehu, Mekdes Shifeta Argaw, Araya Abrha Medhanyie, Damen Hailemariam, Bezaye Nigussie Kassahun, Selamawit Asfaw Beyene, Henok Tadele, Lamesgin Alamineh Endalamaw, Abebech Demissie Aredo, Znabu Hadush Kahsay, Kehabtimer Shiferaw Kotiso, Akalewold Alemayehu, Mulusew Lijalem Belew, Amanuel Hadgu Berhe, Simret Niguse Weldebirhan, Asrat Dimtse, Mesay Hailu Dangisso, Samson Yohannes Amare, Yayeh Negash, Abrham Tariku, John Cramer, Siren Rettedal, Abebe Bekele, Fisseha Ashebir Gebregizabher, Selamawit Mengesha Bilal, Meseret Zelalem Tadesse, Dereje Duguma

PMC · DOI: 10.3390/children13020187 · 2026-01-29

## TL;DR

This study aims to reduce neonatal deaths in Ethiopia by implementing a life-saving care package in 290 hospitals and measuring its impact.

## Contribution

The study introduces a large-scale, non-randomized stepped-wedge trial to evaluate a Minimum Care Package for neonatal survival in Ethiopia.

## Key findings

- The SLL Minimum Care Package will be implemented in 290 hospitals across Ethiopia.
- The study expects an 80% coverage of the interventions to reduce neonatal mortality by 35%.
- Mixed-method assessments will identify barriers and enablers to successful implementation.

## Abstract

Background: Neonatal mortality remains a significant public health challenge in Ethiopia. Despite efforts to implement key evidence-based interventions, their coverage and utilization remain low. The Saving Little Lives (SLL) program aims to scale-up a Minimum Care Package (MCP) of synergistic, life-saving interventions for all liveborn neonates, with a focus on preterm and low birth weight (LBW) infants, across 290 hospitals in Ethiopia (206 primary, 69 general, and 15 referral hospitals), representing 82% of all hospitals in the country at the time of the study, and evaluate the impact on neonatal mortality. Methods: A non-randomized stepped-wedge trial will be conducted to evaluate the impact of implementing the SLL MCP interventions. Quantitative evaluation data will be collected from 36 primary hospitals, selected from 206 primary hospitals across four regions, receiving the interventions. An independent evaluation research assistant will be deployed in each of the hospitals to collect data using Open Data Kit (ODK) through interviewing mothers before discharge, on the 29th day of life if discharged, and reviewing medical records. A mixed-method, cross-sectional formative assessment will be conducted prior to implementation, employing quantitative facility assessment and qualitative interviews with mothers, healthcare providers, and facility managers. This will be followed by continuous program learning assessment once implementation begins. Descriptive data will be presented using numbers, percentages, tables, and graphs. Regression modeling and generalized estimating equations (GEEs) will be used to estimate the impact of the SLL MCP interventions. Qualitative data will be gathered through in-depth interviews, digitally recorded, transcribed, and thematically analyzed using ATLAS.ti Version 7.5 software to assess facility readiness, barriers, and enablers of implementing the SLL MCP interventions. Expected Outcome: We hypothesize that achieving 80% coverage of the SLL MCP interventions among eligible neonates will result in a 35% reduction in neonatal mortality at implementation facilities.

## Full-text entities

- **Genes:** SLC35B2 (solute carrier family 35 member B2) [NCBI Gene 347734] {aka HLD26, PAPST1, SLL, UGTrel4}
- **Diseases:** preterm labor (MESH:D007752), sepsis (MESH:D018805), bacterial infections (MESH:D001424), stillbirths (MESH:D050497), neonatal (MESH:D007232), prematurity (MESH:C536271), Infection (MESH:D007239), preterm and (MESH:D047928), COVID-19 (MESH:D000086382), birth asphyxia (MESH:D001237), LBW (MESH:D001724), malnutrition (MESH:D044342), deaths (MESH:D003643), neonatal death (MESH:D066087), RDS (MESH:D012128), neonatal sepsis (MESH:D000071074), dying (MESH:D064806), injury to (MESH:D014947)
- **Chemicals:** magnesium sulphate (MESH:D008278)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939658/full.md

---
Source: https://tomesphere.com/paper/PMC12939658